Influence of in vivo Hemoglobin Carbamylation on HbA1c Measurements by Various Methods
Authors:
- Christine RandouxCRChristine Randoux
- Hervé MillartHMHervé Millart
- Jacques ChanardJCJacques Chanard
- Philippe GilleryPGPhilippe Gillery
- 30 April 2000
- journal article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 38 (4) , 321-326
Abstract
Increased carbamylated hemoglobin formed in erythrocytes during uremia may interfere with Hba1c assays, but few studies compared directly both parameters. We measured carbamylated hemoglobin by HPLC in 45 non-diabetic uremic patients (16 with acute and two with chronic renal failure, 27 with transplant recipients) as 57.8 ± 22.3 μg carbamylvaline/g Hb (mean ± standard deviation) vs. 31.6 ± 5.1 in 15 controls (+83%, p < 0.001). In these samples, HbA1c was evaluated by three ion-exchange HPLC methods, 1: Diamat (BioRad), 2: A1c2.2 (Tosoh) and 3: HA8140 (Menarini), and one immunoassay method (Tinaquant II Roche). Whichever the method, mean HbA1c values obtained increased in patients with high (> 60 μg carbamylvaline/g Hb) vs. low (< 45) carbamylated hemoglobin values (+0.08 to 0.25% of total Hb), but differences were not significant. Minor peaks on the chromatograms were however increased in parallel to carbamylated hemoglobin. HbA1c values over 6% were found in 4, 1, 2 and 0 samples, with HPLC 1, 2, 3 and immunoassay, respectively. Fructosamine values were not significantly altered. Our results show that Hb adducts, whether due to carbamylation or to other chemical reactions, interfere to a variable extent with different HbA1c assay methods, and confirm that HbA1c values should be interpreted with caution in uremic patients.Keywords
This publication has 26 references indexed in Scilit:
- Evaluation of GHb Assays in France by National Quality Control SurveysDiabetes Care, 1998
- Carbamylated hemoglobin and carbamylated plasma protein in hemodialyzed patientsKidney International, 1998
- Heterogeneity of hemoglobin A1d: assessment and partial characterization of two new minor hemoglobins, A1d3a and A1d3b, increased in uremic and diabetic patients, respectivelyJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- Specificity of hemoglobin A1c measurement by cation exchange liquid chromatography. Evaluation of a Mono S column methodClinica Chimica Acta, 1996
- Carbamylation of erythrocyte membrane proteins: an in vitro and in vivo studyClinical Biochemistry, 1996
- Factors determining hemoglobin carbamylation in renal failureKidney International, 1995
- Carbamylated Hemoglobin in Prerenal AzotemiaNephron, 1995
- Differentiation of acute from chronic renal impairment by detection of carbamylated haemoglobinThe Lancet, 1993
- Carbamylated Haemoglobin, Urea Kinetic Modelling and Adequacy of Dialysis in Haemodialysis PatientsNephrology Dialysis Transplantation, 1991
- Effect of Long-Term Monitoring of Glycosylated Hemoglobin Levels in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1990